8-K - MoonLake Immunotherapeutics (0001821586) (Filer)
Published . Updated .
Key takeaways
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Get these market calls by email
The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.
Free. We only use your email to send the digest, never sell or share it, and every email has a one-click unsubscribe link. See our privacy policy.
8-K - MoonLake Immunotherapeutics filed an 8-K with the SEC on Nov 4 (a notice of a material company event).
Directly affected
- MLTX MoonLake Immunotherapeutics
Named in this report.
Indirectly affected
- XLV Health Care Select Sector SPDR
Health Care Select Sector SPDR holds the health sector that MoonLake Immunotherapeutics belongs to, so it often moves with news about it.
- NVS Novartis AG+1.5% 15d
Novartis AG is a peer of MoonLake Immunotherapeutics in pharmaceutical preparations; rivals often move on the same news.
- AZN AstraZeneca+12.6% 30d
AstraZeneca is a peer of MoonLake Immunotherapeutics in pharmaceutical preparations; rivals often move on the same news.
- NVO Novo Nordisk A/S-7.3% 30d
Novo Nordisk A/S is a peer of MoonLake Immunotherapeutics in pharmaceutical preparations; rivals often move on the same news.
- GSK Gsk-6.8% 8d
Gsk is a peer of MoonLake Immunotherapeutics in pharmaceutical preparations; rivals often move on the same news.
- SNY Sanofi
Sanofi is a peer of MoonLake Immunotherapeutics in pharmaceutical preparations; rivals often move on the same news.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| MLTX | +5.29% | +0.64% | base | after close | after close | after close | after close |
| XLV | -2.31% | +0.48% | base | after close | after close | after close | after close |
| NVS | -1.99% | +0.99% | base | after close | after close | after close | after close |
| AZN | -7.81% | +1.49% | base | after close | after close | after close | after close |
| NVO | -4.80% | -0.53% | base | after close | after close | after close | after close |
| GSK | +0.04% | +1.60% | base | after close | after close | after close | after close |
| SNY | -6.81% | -2.11% | base | after close | after close | after close | after close |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Filed: 2026-11-04 AccNo: 0001821586-26-000013 Size: 289 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
Source: sec-edgar
How far MoonLake Immunotherapeutics (MLTX) has moved since 4 Nov 2026
| Company | When | Move | Status |
|---|---|---|---|
| Astrazeneca (AZN) | three days earlier | +1.49% | final price |
| Astrazeneca (AZN) | five days earlier | -7.81% | final price |
| Gsk (GSK) | three days earlier | +1.60% | final price |
| Gsk (GSK) | five days earlier | +0.04% | final price |
| MoonLake Immunotherapeutics (MLTX) | three days earlier | +0.64% | final price |
| MoonLake Immunotherapeutics (MLTX) | five days earlier | +5.29% | final price |
| Novo Nordisk A S (NVO) | three days earlier | -0.53% | final price |
| Novo Nordisk A S (NVO) | five days earlier | -4.80% | final price |
| Novartis Ag (NVS) | three days earlier | +0.99% | final price |
| Novartis Ag (NVS) | five days earlier | -1.99% | final price |
| Sanofi (SNY) | three days earlier | -2.11% | final price |
| Sanofi (SNY) | five days earlier | -6.81% | final price |
| Select Sector Spdr Tr (XLV) | three days earlier | +0.48% | final price |
| Select Sector Spdr Tr (XLV) | five days earlier | -2.31% | final price |
Congressional trades in the stocks in this story
- Rep. Kevin Hern sold Novartis Ag (NVS), worth $15,001 - $50,000 on 27 Aug 2026. That is 69 days before publication. Filed 25 Sep 2026. View the filing.
- Rep. Kevin Hern sold Novo Nordisk A S (NVO), worth $1,001 - $15,000 on 10 Sep 2026. That is 55 days before publication. Filed 25 Sep 2026. View the filing.
- Rep. Kevin Hern sold Novo Nordisk A S (NVO), worth $1,001 - $15,000 on 31 Aug 2026. That is 65 days before publication. Filed 25 Sep 2026. View the filing.
- Rep. Scott Scott Franklin bought Novo Nordisk A S (NVO), worth $1,001 - $15,000 on 26 Aug 2026. That is 70 days before publication. Filed 17 Sep 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
Who is named in “8-K - MoonLake Immunotherapeutics (0001821586) (Filer)”
Companies mentioned with this story
- MLTX MoonLake Immunotherapeutics
In “8-K - MoonLake Immunotherapeutics (0001821586) (Filer),” MoonLake Immunotherapeutics (MLTX) is linked, with no stored direction, high confidence. Reason on file: SEC 8-K filing -> direct issuer disclosure -> MLTX
- XLV Select Sector Spdr Tr
In “8-K - MoonLake Immunotherapeutics (0001821586) (Filer),” Select Sector Spdr Tr (XLV) is linked, with no stored direction, medium confidence. Reason on file: Health Care Select Sector SPDR holds the health sector that MoonLake Immunotherapeutics belongs to, so it often moves with news about it
- NVS Novartis Ag
In “8-K - MoonLake Immunotherapeutics (0001821586) (Filer),” Novartis Ag (NVS) is linked, with no stored direction, medium confidence. Reason on file: Novartis AG is a peer of MoonLake Immunotherapeutics in pharmaceutical preparations; rivals often move on the same news
- AZN Astrazeneca
In “8-K - MoonLake Immunotherapeutics (0001821586) (Filer),” Astrazeneca (AZN) is linked, with no stored direction, medium confidence. Reason on file: AstraZeneca is a peer of MoonLake Immunotherapeutics in pharmaceutical preparations; rivals often move on the same news
- NVO Novo Nordisk A S
In “8-K - MoonLake Immunotherapeutics (0001821586) (Filer),” Novo Nordisk A S (NVO) is linked, with no stored direction, medium confidence. Reason on file: Novo Nordisk A/S is a peer of MoonLake Immunotherapeutics in pharmaceutical preparations; rivals often move on the same news
- GSK Gsk
Gsk (GSK) is linked, with no stored direction, medium confidence in the 4 Nov 2026 story “8-K - MoonLake Immunotherapeutics (0001821586) (Filer).” Reason on file: Gsk is a peer of MoonLake Immunotherapeutics in pharmaceutical preparations; rivals often move on the same news
- SNY Sanofi
In “8-K - MoonLake Immunotherapeutics (0001821586) (Filer),” Sanofi (SNY) is linked, with no stored direction, medium confidence. Reason on file: Sanofi is a peer of MoonLake Immunotherapeutics in pharmaceutical preparations; rivals often move on the same news
How “8-K - MoonLake Immunotherapeutics (0001821586) (Filer)” reaches MoonLake Immunotherapeutics (MLTX)
The 4 Nov 2026 story “8-K - MoonLake Immunotherapeutics (0001821586) (Filer)” names MoonLake Immunotherapeutics (MLTX) because of this story.
The link for MoonLake Immunotherapeutics (MLTX) is this: SEC 8-K filing -> direct issuer disclosure -> MLTX
Also listed, Select Sector Spdr Tr (XLV): Health Care Select Sector SPDR holds the health sector that MoonLake Immunotherapeutics belongs to, so it often moves with news about it
Dates in the story, and the MoonLake Immunotherapeutics (MLTX) price range
MLTX traded between 10.71 and 11.40 across 2 sessions. The latest close on file is 10.78. NVS traded between 139.43 and 147.02 across 12 sessions. The latest close on file is 140.78.
What the saved facts support for MoonLake Immunotherapeutics (MLTX)
46 out of 100
“8-K - MoonLake Immunotherapeutics (0001821586) (Filer)” scores 46 out of 100. The score uses 1 sources, and 7 linked companies.